DoT cellsexpress MHC II T-cells and peptides are fundamental components of the adaptive immune system, working in concert to recognize and respond to foreign invaders and abnormal cells. The interaction between t-cells peptide fragments presented on Major Histocompatibility Complex (MHC) molecules is a critical event that dictates the specificity and efficacy of immune responses. Understanding this interaction is crucial for fields ranging from immunology research to vaccine development and cancer immunotherapyTCRmediated recognition of a peptide antigen bound to an MHC-derived moleculerepresents a central event for cellular immune responses. Cytotoxic T lymphocytes ....
T-cells, a type of lymphocyte, are equipped with T-cell receptors (TCRs) that are designed to survey the body for signs of infection or disease. However, TCRs do not directly recognize intact proteins.作者：JF Mohan·2012·被引用次数：104—Here, we discussunconventional peptide recognition by type BT cellsand consider the implications for type 1 diabetes and other autoimmune diseases. Instead, they recognize short fragments of proteins, known as peptides, which are processed from larger molecules and then presented on the surface of other cells. This presentation is facilitated by MHC molecules.
There are two main classes of MHC molecules involved:
* MHC Class I molecules are found on almost all nucleated cells in the body作者：JF Mohan·2012·被引用次数：104—Here, we discussunconventional peptide recognition by type BT cellsand consider the implications for type 1 diabetes and other autoimmune diseases.. They typically present peptides derived from intracellular proteins, including viral proteins or abnormal cellular proteins (e.g., cancer antigens). Cytotoxic T lymphocytes (CTLs), specifically CD8+ T-cells, recognize these peptide-MHC Class I complexes作者：F Kiecker·2004·被引用次数：150—For stimulating T cells, peptides must be bound to MHC molecules. In this study we have used 9- or 10-amino acid peptides, 15-amino acid peptides containing .... Upon recognition, CD8+ T-cells can eliminate the infected or cancerous cell.
* MHC Class II molecules are primarily expressed on professional antigen-presenting cells (APCs) such as dendritic cells, macrophages, and B cells. They present peptides derived from extracellular proteins that have been taken up and processed by the APCThe T cell encounters a dendritic cell (DC) bearing its cognate peptidein an MHC molecule, and binds the peptide-MHC though CD3 and CD4 or 8. Subsequently .... Helper T-cells, typically CD4+ T-cells, recognize these peptide-MHC Class II complexes. Activated helper T-cells then orchestrate broader immune responses, including helping B-cells produce antibodies and activating other immune cells.作者：SAE Galloway·2019·被引用次数：24—Overall, we conclude thatsuper agonist peptide MTSAIGILPV can prime a greater quantity of T-cellsthan is generated by the natural sequence EAAGIGILTV and that ...
The TCR's ability to bind to a specific peptide presented by an MHC molecule is highly specific. This specificity is what allows the immune system to mount targeted responses against a vast array of pathogens and antigens.
Peptides involved in T-cell recognition can originate from various sources:
* Pathogen-derived peptides: These are fragments of proteins from bacteria, viruses, or other infectious agents. Their recognition by T-cells is a key mechanism for clearing infections. For instance, specific viral peptides presented by MHC molecules can prime CD8+ T-cells to seek out and destroy infected cellsDifferential Activation of T Cells by Natural Antigen Peptide ....
* Self-peptides: These are fragments of the body's own proteinsUnconventional recognition of peptides by T cells and the .... Normally, T-cells are educated during their development in the thymus to tolerate self-peptides, preventing autoimmune reactions. However, in certain autoimmune diseases, T-cells may mistakenly recognize self-peptides presented by MHC molecules, leading to an immune attack on the body's own tissues.作者：CA Janeway Jr·2001·被引用次数：3—T cells do this byrecognizing peptide fragments of pathogen-derived proteinsin the form of complexes of peptides and MHC molecules on the cell surface. Unconventional recognition of self-peptides by T-cells is a significant area of study in autoimmune conditions like type 1 diabetes.
* Tumor-associated peptides: Cancer cells often produce abnormal proteins, or overexpress normal proteins, that can be processed into peptides. These tumor-associated peptides, when presented by MHC molecules on cancer cells, can be recognized by T-cells, forming the basis for cancer immunotherapyIn this protocol, you'll learnhow to prepare peptide pool stocks and PBMC suspensions, activate T cells and quantify antigen-specific responses using flow .... Strategies involve stimulating T-cells to recognize these tumor peptides, thereby mounting an anti-cancer response.How the T Cell Repertoire Becomes Peptide and MHC ...
* Synthetic and engineered peptides: In research and therapeutic settings, synthetic peptides are widely usedThe T cell encounters a dendritic cell (DC) bearing its cognate peptidein an MHC molecule, and binds the peptide-MHC though CD3 and CD4 or 8. Subsequently .... These can be designed to mimic natural antigens for T-cell stimulation, or they can be modified to enhance T-cell responses.Nonstimulatory peptide–MHC enhances human T-cell ... For example, "super agonist" peptides have been developed that can prime a greater quantity of T-cells than their natural counterparts. Peptide libraries are also available for broad screening and T-cell activation studies.
The ability to stimulate or modulate T-cell responses using peptides is a cornerstone of modern immunology and therapeutics.
* T-Cell Stimulation: Researchers often use specific peptides, sometimes in pools, to activate antigen-specific T-cells in vitro.In this protocol, you'll learnhow to prepare peptide pool stocks and PBMC suspensions, activate T cells and quantify antigen-specific responses using flow ... This is crucial for studying immune responses, identifying T-cell epitopes, and developing T-cell-based therapies. Protocols exist for preparing peptide pool stocks, stimulating T-cells, and quantifying antigen-specific responsesDifferent Types of T Cells and Their Functions - Akadeum Life Sciences.
* Vaccine Development: Many vaccines work by presenting specific pathogen-derived peptides (often bound to MHC molecules) to the immune system, thereby inducing a robust T-cell response that primes the body for future encounters with the actual pathogen.
* Cancer Immunotherapy: Approaches such as peptide vaccines aim to stimulate a patient's T-cells to recognize and attack cancer cells. Similarly, engineered T-cell receptors (TCRs) that are specific for tumor-associated peptides can be introduced into a patient's T-cells to enhance their anti-cancer activityThe T cell encounters a dendritic cell (DC) bearing its cognate peptidein an MHC molecule, and binds the peptide-MHC though CD3 and CD4 or 8. Subsequently ....
* Peptide Therapy: While less broadly applied than other modalities, peptide therapy is being explored for various conditions, with some studies examining its effects on ex vivo T-cell responses, potentially by altering T-cell phenotype or function.作者：JF Mohan·2012·被引用次数：104—Here, we discussunconventional peptide recognition by type BT cellsand consider the implications for type 1 diabetes and other autoimmune diseases.
Despite significant progress, understanding the intricate dance between peptides and T-cells continues to evolve.2022年8月2日—Peptide-specific CD8+T cellshave typically expanded enough by day 9 or 10to be visible above the limit of detection in several assays, ... Challenges include the sheer diversity of peptides and TCRs, the complex mechanisms governing peptide binding to MHC molecules, and the nuanced ways T-cells are activated or tolerized.Peptide presentation and T-cell activation. The TCR ... For instance, while TCRs are generally considered to recognize specific peptide-MHC complexes, there is also evidence of unconventional peptide recognition, where TCRs can respond to peptides unrelated to their primary target under certain circumstances作者：SAE Galloway·2019·被引用次数：24—Overall, we conclude thatsuper agonist peptide MTSAIGILPV can prime a greater quantity of T-cellsthan is generated by the natural sequence EAAGIGILTV and that ....
Further research into how T-cell receptors achieve high specificity toward a peptide antigen, how self-peptides influence T-cell development, and how to therapeutically leverage peptide-MHC interactions holds immense promise for treating a wide range of human diseases. The development of novel peptide libraries and sophisticated assays for analyzing antigen-specific T-cell responses continues to push the boundaries of immunological research and clinical application.Differential Activation of T Cells by Natural Antigen Peptide ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.